GALACTIC HF
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects With Chronic Heart Failure With Reduced Ejection Fraction
- Stage
- klaar
- Medicine
- omecamtiv mecarbil
- Population
- Hartfalen
- Phase
- III
- First Patient In
- 6 July 2017
- Last Patient In
- 28 June 2019
- Last Patient Last Visit
- 30 September 2020